nach oben

Erschienen in:

01.06.2019 | Clinical study

Inactivated versus live influenza vaccines in children with asthma

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In children with asthma, nasal administration of a live attenuated influenza vaccine (LAIV) does not appear to be associated with an increased risk of lower respiratory events (LREs) compared with use of an intramuscular inactivated influenza vaccine (IIV), according to study results reported in Vaccine. …

Nordin JD, et al. Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma. Vaccine : 10 Jun 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.05.081

Titel: Inactivated versus live influenza vaccines in children with asthma
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63897-8

Dexamethasone/gentamicin

Case report

Fingolimod

Case report

Immune-globulin/mycophenolate/prednisone

Case report

Capecitabine

Case report

Ciclesonide/fluticasone-propionate

Case report

Prednisolone

Case report

Springer Medizin

Inactivated versus live influenza vaccines in children with asthma

Excerpt

Weitere Artikel der Ausgabe 1/2019

Dexamethasone/gentamicin

Fingolimod

Immune-globulin/mycophenolate/prednisone

Capecitabine

Ciclesonide/fluticasone-propionate

Prednisolone

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Dexamethasone/gentamicin

Fingolimod

Immune-globulin/mycophenolate/prednisone

Capecitabine

Ciclesonide/fluticasone-propionate

Prednisolone